Regulatory Science and Clinical Affairs
Provide in-depth knowledge of Regulatory Science applied at a national and international level, the way in which the different actors
collaborate in regulation and the current needs of the system to which the Academy must contribute. main regulatory structures, their
powers and duties, applicable legislation and regulations. Students acquire basic competence in the various methodologies used for
quality control and pre-clinical development of health products, and will develop knowledge and skills in the field of medicine related
to the clinical development of products, as well as their follow-up throughout the product's life cycle. The pre-defined objectives are in
line with the FMUL's Mission and the strategy it has been developing in the postgraduate area. In addition, they reinforce the
scientific and pedagogical components.
• This program aims to provide professional training in this area, which will facilitate applications for research projects in the area of regulatory science
• Integration into multidisciplinary teams in the pharmaceutical industry, in the regulatory authority and in assistance areas (ULS/Hospital Pharmacy and Therapeutics Committees);
• Integration into research and innovation teams in regulatory science with the promotion of collaborations between the university and scientists in the regulatory network to address research questions in emerging regulatory sciences;
Access and ingress
Graduates/Integrated Masters or legal equivalents in Medicine, and other areas of Health Sciences and related areas, biomathematics, biomedical engineering, as well as professionals from the pharmaceutical industry can apply for this EC. Holders of a foreign higher academic study, in the same areas, granted following a 1st cycle organized in accordance with the principles of the Bologna Process or that are recognized as satisfying the objectives of the licentiate degree by the scientific and statutorily competent body.
New cycle of studies